U.K. researchers find that taste buds respond differently to depression therapies that target serotonin and noradrenaline, and this finding can be used to determin the appropriate antidepressant for depressive patients. The report is published in The Journal of Neuroscience.
When faced with a depressed patient, clinicians often have to choose a proper course of treatment based on a guess as to which neurotransmitter in the brain is being disrupted–serotonin, noradrenaline or both.
This report could result in an easier way of putting patients on a path to mental stability.